In this issue:
Advancing diagnostic excellence and health equity: PSA screening
Systemic therapy in patients with mCRPC: ASCO guideline update
NICE prostate cancer resources in development
TGA registrations
July amendments to the MBS
New items: theranostics for mCRPC
Outcome on MBS item for focal irreversible electroporation pending
Annual indexation factor
Changes to management of chronic conditions & general medical services
FDA approves darolutamide for mCSPC
EMA warns of risk of suicidal thoughts with finasteride
Carotuximab combo safe in mCRPC
ESMO Asia Congress 2025
Conferences & Workshops
Please login below to download this issue (PDF)